Team 60

gliaX

An agentic AI drug discovery platform that leverages biological foundation models and molecular simulations to evaluate existing drugs, design novel therapeutics, visualize predicted biological interactions in 3D

Check your own project

Community votes recognize the build and do not affect official judging.

Review the project

Start with the source code, then open the demo or video if available.

View GitHub repository
Project description
An AI-driven drug discovery platform that integrates scientific agents, biological foundation models, molecular simulations, and public biomedical databases to evaluate existing drugs and discover novel therapeutic candidates. The platform operates through two complementary tracks: Known Drug Evaluation, which predicts drug suitability and biological responses using patient-specific genomic and cellular data or reference datasets, and De Novo Drug Discovery, which identifies disease-specific molecular targets, generates and optimizes candidate compounds, and evaluates their predicted binding, efficacy, and toxicity. By combining cross-species evaluation across animal and human biological models with interactive 3D visualization, the system iteratively refines therapeutic hypotheses and proposes evidence-based wet-lab experiments for validation.
Tools used